Skip to content

Early and Late Prognosis in Patients With Guillain-Barre Syndrome

Early and Late Prognosis in Patients With Guillain-Barre Syndrome

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06041451
Enrollment
450
Registered
2023-09-18
Start date
2013-01-02
Completion date
2025-01-31
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Guillain-Barre Syndrome

Keywords

Guillain-barre syndrome, prognosis

Brief summary

The goal of this observational study is to explore significant indicators to predict the early prognosis and late prognosis in patients with Guillain-Barre syndrome.

Detailed description

This is a multicenter study(approximately three) with over 450 subjects.Clinical data were collected by consulting the patient's electronic history. The data included demographic information, blood biochemical markers, clinical characteristics and electromyography. All participants provided their written informed consent to participate in this study.

Interventions

patients were treated with intravenous immunoglobulin(30g ivgtt qd) for 5 days

DRUGMethylprednisolone 500 MG Injection

patients were treated with methylprednisolone

Sponsors

First Affiliated Hospital of Wenzhou Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* patients fulfilled clinical, biological, and electrophysiology criteria for Guillain-barre syndrome.

Exclusion criteria

* nonidiopathic Guillain-barre syndrome and Miller Fisher syndrome

Design outcomes

Primary

MeasureTime frameDescription
the severity of Guillain-barre syndromebaseline, at 1 week, at 26 weeksThe Guillain-barre syndrome disability score is a wide scale for the severity of Guillain-barre syndrome (0, optimal health; 1, minor symptoms, able to run; 2, able to walk unaided 10 m, unable to run; 3, able to walk 10 m across an open space with help; 4 bedridden or wheelchair users; 5, require assisted ventilation; 6, dead).The higher the score, the worse the prognosis.

Countries

China

Contacts

Primary ContactBinbin Deng
dbinbin@aliyun.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026